Zobrazeno 1 - 10
of 34
pro vyhledávání: '"LB Montejano"'
Publikováno v:
Pain Practice. 12:633-640
Background: Osteoarthritis is a chronic debilitating condition affecting many adults in the United States. This study was to compare pharmacologic treatments and costs for newly diagnosed and existing osteoarthritis patients to assess unmet medicatio
Publikováno v:
Current Medical Research and Opinion. 27:5-11
The burden of attention-deficit/hyperactivity disorder (ADHD) in adults is increasingly recognized. This retrospective analysis was designed to estimate the prevalence of diagnosed ADHD in a population of insured, employed individuals and their depen
Autor:
Brian Cuffel, Leslie Citrome, Gregory Lenhart, Kafi N. Sanders, Liisa Palmer, Christopher Reist, James Harnett, LB Montejano
Publikováno v:
Schizophrenia Research. 115:115-120
The purpose of this study is to evaluate the relationship between maximum dose of ziprasidone and time to discontinuation in the treatment of schizophrenia/schizoaffective disorder and bipolar disorder in clinical practice.The 2001-2006 MarketScan Co
Publikováno v:
Value in Health. 19:A49-A50
Publikováno v:
Journal of Pain Research, Vol 2012, Iss default, Pp 23-30 (2012)
T Kim Le1, Leslie B Montejano2, Zhun Cao2, Yang Zhao1, Dennis Ang31Eli Lilly and Company, Indianapolis, IN, 2Thomson Reuters, Washington, DC, 3Indiana University School of Medicine, Indianapolis, IN, USABackground: Osteoarthritis is a chronic and cos
Publikováno v:
The Primary Care Companion For CNS Disorders.
Attention-deficit/hyperactivity disorder (ADHD) is a neurobehavioral condition characterized by core symptoms of inattentiveness, hyperactivity, and impulsivity that can manifest as disruptions in the academic, social, and home settings.1 Although on
Publikováno v:
Journal of Urology. 185
INTRODUCTION AND OBJECTIVES: Interstitial cystitis (IC) and painful bladder syndrome (PBS) are related conditions, affecting 1–17% of women and 0.25–5% percent of men (Clemens et al. J Urol 2005; Clemens et al. J Urol 2007; Ibrahim et al. Int Uro
Publikováno v:
Value in Health. 12(3)
Publikováno v:
Value in Health. 12(3)
Autor:
Liisa Palmer, LB Montejano, Leslie Citrome, Kafi N. Sanders, Greg Lenhart, James Harnett, Brian Cuffel, Christopher Reist
Publikováno v:
Schizophrenia research. 108(1-3)
Background Antipsychotic dosing used in clinical practice can differ from dosing originally recommended in product labeling. This has been reported for olanzapine and quetiapine, where higher doses are commonly used. This may be the case for ziprasid